A mistrial was declared for 3 counts within the Elizabeth Holmes trial.

A mistrial was formally declared for 3 counts of wire fraud towards Elizabeth Holmes, the founding father of the failed blood-testing start-up Theranos, based on a federal courtroom filing released on Tuesday.

Ms. Holmes, 37, was found guilty on Monday of three counts of wire fraud and one depend of conspiracy to commit wire fraud for mendacity to buyers to lift cash for her firm. She was discovered not responsible on 4 counts associated to defrauding Theranos’s sufferers.

The three hung counts have been associated to investments from three Theranos buyers who testified that Ms. Holmes misled them. Jurors had mentioned on Monday that they might not agree on verdicts on these counts. A listening to will be held next week to debate these costs, which prosecutors might select to retry.

Ms. Holmes — a Stanford College dropout and one-time start-up darling turned Silicon Valley pariah — can be anticipated to obtain a sentencing date at subsequent week’s listening to for the counts she was convicted on. Every wire fraud depend carries a most sentence of 20 years in jail. Ms. Holmes can attraction her conviction, the sentencing or each.

The hung counts got here after a jury of eight men and four women spent 50 hours over seven days deliberating a verdict. On Monday, they twice advised Decide Edward J. Davila of america District Courtroom for the Northern District of California, who presided over the case, that they have been deadlocked on the three counts towards Ms. Holmes. Verdicts have been delivered on the opposite eight counts as an alternative.

The three hung counts associated to the buyers Alan Eisenman, Chris Lucas of Black Diamond Ventures and Bryan Tolbert of the Corridor Group. Every had invested in Theranos, with a few of their transactions forming the idea of three counts of wire fraud.

Mr. Eisenman testified that he believed Ms. Holmes was hiding info from him. Mr. Lucas testified that Ms. Holmes was his essential supply of details about Theranos. Mr. Tolbert mentioned in courtroom that he backed Theranos on the understanding that its expertise was able to be deployed.

Traders’ due diligence — and lack thereof — was a serious theme through the case, which was considered as a verdict on Silicon Valley’s culture of hype and hustle.

In whole, Theranos raised $945 million from buyers over its lifetime. These investments have been worn out after the corporate’s blood assessments — which have been supposed to have the ability to discern numerous illnesses from a number of drops of a affected person’s blood — have been proven to not work.